{"classification":[{"coding":[{"code":"chemical","display":"Chemical","system":"http://example.europa.eu/fhir/SubstanceType"}]}],"code":[{"code":{"coding":[{"code":"PONA4321C","system":"http://example.europa.eu/fhir/Substance"}]}}],"description":"Ponatinib hydrochloride — a small-molecule tyrosine kinase inhibitor (TKI) used in the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Hydrochloride salt of ponatinib.","domain":{"coding":[{"code":"human","display":"Human use","system":"http://example.europa.eu/fhir/Domain"}]},"id":"ponatinib-hcl","identifier":[{"system":"http://example.europa.eu/fhir/SMSId","value":"PONA4321C"}],"moiety":[{"molecularFormula":"C29H27F3N6O","name":"Ponatinib","role":{"coding":[{"code":"active-moiety","display":"Active moiety","system":"http://example.europa.eu/fhir/MoietyRole"}]}},{"molecularFormula":"HCl","name":"Hydrochloride","role":{"coding":[{"code":"counter-ion","display":"Counter-ion (salt)","system":"http://example.europa.eu/fhir/MoietyRole"}]}}],"molecularWeight":[{"amount":{"code":"g/mol","system":"http://unitsofmeasure.org","unit":"g/mol","value":569.04},"type":{"coding":[{"code":"exact","display":"Exact","system":"http://example.europa.eu/fhir/WeightType"}]}}],"name":[{"language":[{"coding":[{"code":"en","display":"English","system":"urn:ietf:bcp:47"}]}],"name":"Ponatinib Hydrochloride","official":[{"authority":{"coding":[{"code":"USAN","display":"USAN","system":"http://hl7.org/fhir/substance-name-authority"}]},"status":{"coding":[{"code":"active","display":"Active","system":"http://hl7.org/fhir/publication-status"}]}}],"preferred":true}],"relationship":[{"amountQuantity":{"code":"nmol/L","system":"http://unitsofmeasure.org","unit":"nM","value":0.37},"interaction":{"coding":[{"code":"inhibition","display":"Inhibition","system":"http://hl7.org/fhir/substance-interaction-type"}]},"measurementType":{"coding":[{"code":"ic50","display":"IC50","system":"http://hl7.org/fhir/substance-measurement-type"}]},"substanceDefinitionCodeableConcept":{"coding":[{"code":"A9UF07","display":"BCR-ABL1 fusion kinase","system":"https://www.uniprot.org"}]},"type":{"coding":[{"code":"TherapeuticTarget","display":"Therapeutic target","system":"http://hl7.org/fhir/substance-relationship-type"}]}}],"resourceType":"SubstanceDefinition","status":{"coding":[{"code":"active","display":"Active","system":"http://hl7.org/fhir/publication-status"}]}}